195 related articles for article (PubMed ID: 28403842)
1. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
[TBL] [Abstract][Full Text] [Related]
2. Improvement in gross motor function and muscle tone in children with cerebral palsy related to neonatal icterus: an open-label, uncontrolled clinical trial.
Thanh LN; Trung KN; Duy CV; Van DN; Hoang PN; Phuong ANT; Ngo MD; Thi TN; Viet AB
BMC Pediatr; 2019 Aug; 19(1):290. PubMed ID: 31438885
[TBL] [Abstract][Full Text] [Related]
3. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy.
Nguyen TL; Nguyen HP; Nguyen TK
Health Qual Life Outcomes; 2018 Aug; 16(1):164. PubMed ID: 30107811
[TBL] [Abstract][Full Text] [Related]
4. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study.
Wang X; Cheng H; Hua R; Yang J; Dai G; Zhang Z; Wang R; Qin C; An Y
Cytotherapy; 2013 Dec; 15(12):1549-62. PubMed ID: 24100132
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety.
Zali A; Arab L; Ashrafi F; Mardpour S; Niknejhadi M; Hedayati-Asl AA; Halimi-Asl A; Ommi D; Hosseini SE; Baharvand H; Aghdami N
Cytotherapy; 2015 Feb; 17(2):232-41. PubMed ID: 25593079
[TBL] [Abstract][Full Text] [Related]
6. Administration of Autologous Bone Marrow-Derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept.
Bansal H; Singh L; Verma P; Agrawal A; Leon J; Sundell IB; Koka PS
J Stem Cells; 2016; 11(1):37-49. PubMed ID: 28296863
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy.
Liu X; Fu X; Dai G; Wang X; Zhang Z; Cheng H; Zheng P; An Y
J Transl Med; 2017 Feb; 15(1):48. PubMed ID: 28235424
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.
Mancías-Guerra C; Marroquín-Escamilla AR; González-Llano O; Villarreal-Martínez L; Jaime-Pérez JC; García-Rodríguez F; Valdés-Burnes SL; Rodríguez-Romo LN; Barrera-Morales DC; Sánchez-Hernández JJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Gómez-De León A; Elizondo-Riojas G; Salazar-Riojas R; Gómez-Almaguer D
Cytotherapy; 2014 Jun; 16(6):810-20. PubMed ID: 24642016
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.
Chen G; Wang Y; Xu Z; Fang F; Xu R; Wang Y; Hu X; Fan L; Liu H
J Transl Med; 2013 Jan; 11():21. PubMed ID: 23351389
[TBL] [Abstract][Full Text] [Related]
10. An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability.
Sharma A; Sane H; Gokulchandran N; Pai S; Kulkarni P; Ganwir V; Maheshwari M; Sharma R; Raichur M; Nivins S; Badhe P
Stem Cell Res Ther; 2018 Jan; 9(1):19. PubMed ID: 29386049
[TBL] [Abstract][Full Text] [Related]
11. PROSPECTIVE SINGLE CENTER ANALYSIS OF OUTCOME STEM CELLS TRANSPLANTS IN PATIENTS WITH CEREBRAL PALSY.
Yousif NG; Yousif MG; Mohsen AAU; El-Bakaa HS; Younise MH; Altimimi AN; Nöth UA; Hassan AM
Pol Merkur Lekarski; 2023; 51(4):339-345. PubMed ID: 37756453
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with autologous M2 macrophages in children with severe cerebral palsy.
Chernykh ER; Kafanova MY; Shevela EY; Sirota SI; Adonina EI; Sakhno LV; Ostanin AA; Kozlov VV
Cell Transplant; 2014; 23 Suppl 1():S97-104. PubMed ID: 25302537
[TBL] [Abstract][Full Text] [Related]
13. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
14. Encouraging effect of autologous bone marrow aspirate concentrate in rehabilitation of children with cerebral palsy.
Maric DM; Radomir M; Milankov Z; Stanojevic I; Vojvodic D; Velikic G; Susnjevic S; Maric DL; Abazovic D
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2330-2342. PubMed ID: 35442487
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal construct validity of the GMFM-88 total score and goal total score and the GMFM-66 score in a 5-year follow-up study.
Lundkvist Josenby A; Jarnlo GB; Gummesson C; Nordmark E
Phys Ther; 2009 Apr; 89(4):342-50. PubMed ID: 19220999
[TBL] [Abstract][Full Text] [Related]
16. An observational study of autologous bone marrow-derived stem cells transplantation in seven patients with nervous system diseases: a 2-year follow-up.
Ren C; Geng RL; Ge W; Liu XY; Chen H; Wan MR; Geng DQ
Cell Biochem Biophys; 2014 May; 69(1):179-87. PubMed ID: 24062130
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.
Liao GP; Harting MT; Hetz RA; Walker PA; Shah SK; Corkins CJ; Hughes TG; Jimenez F; Kosmach SC; Day MC; Tsao K; Lee DA; Worth LL; Baumgartner JE; Cox CS
Pediatr Crit Care Med; 2015 Mar; 16(3):245-55. PubMed ID: 25581630
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
19. Predictors for the benefit of selective dorsal rhizotomy.
Funk JF; Panthen A; Bakir MS; Gruschke F; Sarpong A; Wagner C; Lebek S; Haberl EJ
Res Dev Disabil; 2015 Feb; 37():127-34. PubMed ID: 25460226
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.
Taguchi A; Sakai C; Soma T; Kasahara Y; Stern DM; Kajimoto K; Ihara M; Daimon T; Yamahara K; Doi K; Kohara N; Nishimura H; Matsuyama T; Naritomi H; Sakai N; Nagatsuka K
Stem Cells Dev; 2015 Oct; 24(19):2207-18. PubMed ID: 26176265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
